Human Serum albumin (HSA), the most abundant serum protein in blood plasma, plays a crucial role as a transport protein for both endogenous metabolites and exogenous drugs, making it essential for understanding drug pharmacokinetics. Among various analytical methods, fluorescent probe technology stands out as a powerful tool for analysing the binding sites and binding characteristics of drugs-HSA interactions. However, most reported fluorescent probes bind exclusively to either subdomain IIA or subdomain IIIA of HSA, significantly limiting their applicability. In this study, a series of fluorogenic probes featuring a donor-π-acceptor (D-π-A) system was systematically explored. We found that probes containing a quinolinium moiety target the subdomain IB region of HSA and demonstrate good selectivity towards HSA. This observation also agrees with our computational studies. Notably, enhancing the lipophilicity of the acceptor moiety, rather than increasing the steric hindrance of the donor, improved both selectivity and binding affinity toward HSA. Among the developed probes, HSAtag-3-14C exhibited a remarkable fluorescence enhancement (∽2000-fold) upon binding to HSA, with emission in the near-infrared region. The dissociation constant of HSAtag-3-14C was determined to be 17.8 ± 2.6 μM at 25 °C, and its limit of detection was 0.28 ± 0.01 nM. In addition, MD simulations were performed to investigate interactions between the HSAtag-3 series and HSA. The binding of HSAtag-3-14C is predominantly driven by hydrophobic interactions, with a nonpolar pocket formed by Leu115, Pro118, and Ile142 providing a favorable environment for stabilizing the aliphatic chain. In contrast, HSAtag-3 binding is mainly governed by electrostatic interactions. These results suggest that extending the alkyl chain length is an effective strategy to enhance HSA binding affinity, consistent with its role as a fatty acid–binding protein.
扫码关注我们
求助内容:
应助结果提醒方式:
